ABCA1: at the nexus of cholesterol, HDL and atherosclerosis

Alan D Attie1

  • 1Department of Biochemistry, University of Wisconsin-Madison, Madison, WI 53706, USA. attie@biochem.wisc.edu

Insights

The ATP-binding cassette transporter A1 (ABCA1) is vital for cellular cholesterol homeostasis. This lipid transporter plays a key role in forming high-density lipoprotein (HDL) and preventing atherosclerosis.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Cardiovascular Science

Background:

  • Cholesterol is essential for eukaryotic cell membranes.
  • Cholesterol overload can be toxic to cells.
  • The ATP-binding cassette transporter A1 (ABCA1) facilitates cholesterol transport.

Purpose of the Study:

  • To investigate the role of ABCA1 in cholesterol transport and high-density lipoprotein (HDL) formation.
  • To understand the implications of ABCA1 function in atherosclerosis.

Main Methods:

  • Studies involving mutations in ABCA1.
  • Analysis of ABCA1's transport of cholesterol and phospholipids.
  • Examination of ABCA1's role in intestinal and arterial wall cholesterol metabolism.

Main Results:

  • Mutations in ABCA1 are linked to HDL-deficiency syndromes.
  • ABCA1 is crucial for the formation of HDL particles by transporting cholesterol and phospholipids to apolipoprotein acceptors.
  • ABCA1 contributes significantly to HDL production in the intestine.
  • ABCA1 exhibits anti-atherogenic properties by facilitating cholesterol efflux from macrophages in the arterial wall.

Conclusions:

  • ABCA1 is essential for maintaining cholesterol balance and preventing toxicity.
  • ABCA1 plays a critical role in both the production of HDL and the prevention of atherosclerosis.

Related Concept Videos

Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Lipid Absorption01:24

Lipid Absorption

Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Inflammation01:38

Inflammation

Overview